CN100435843C - 一种胸腺五肽与干扰素的组合物 - Google Patents
一种胸腺五肽与干扰素的组合物 Download PDFInfo
- Publication number
- CN100435843C CN100435843C CNB2006100762710A CN200610076271A CN100435843C CN 100435843 C CN100435843 C CN 100435843C CN B2006100762710 A CNB2006100762710 A CN B2006100762710A CN 200610076271 A CN200610076271 A CN 200610076271A CN 100435843 C CN100435843 C CN 100435843C
- Authority
- CN
- China
- Prior art keywords
- thymopentin
- interferon
- injection
- solution
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100762710A CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100762710A CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1833721A CN1833721A (zh) | 2006-09-20 |
CN100435843C true CN100435843C (zh) | 2008-11-26 |
Family
ID=37001711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100762710A Active CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100435843C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078598B (zh) * | 2011-01-06 | 2012-11-28 | 河南亚卫动物药业有限公司 | 一种防治猪病毒性疾病的注射剂及其制备方法 |
CN108721603B (zh) * | 2017-04-14 | 2020-11-13 | 中国医学科学院基础医学研究所 | 干扰素α-1a在制备用于治疗癌症的药物中的用途 |
CN111671886B (zh) * | 2020-03-05 | 2022-11-15 | 上海甘翼生物医药科技有限公司 | 一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037306A1 (en) * | 2003-10-17 | 2005-04-28 | Novo Nordisk A/S | Combination therapy |
CN1676162A (zh) * | 2004-03-30 | 2005-10-05 | 北京中科亚光生物科技有限公司 | 一种胸腺五肽注射液 |
EP1611879A1 (en) * | 2004-07-02 | 2006-01-04 | Novagali Pharma SA | Use of emulsions for intra- and periocular injection |
-
2006
- 2006-04-21 CN CNB2006100762710A patent/CN100435843C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037306A1 (en) * | 2003-10-17 | 2005-04-28 | Novo Nordisk A/S | Combination therapy |
CN1676162A (zh) * | 2004-03-30 | 2005-10-05 | 北京中科亚光生物科技有限公司 | 一种胸腺五肽注射液 |
EP1611879A1 (en) * | 2004-07-02 | 2006-01-04 | Novagali Pharma SA | Use of emulsions for intra- and periocular injection |
Non-Patent Citations (4)
Title |
---|
慢性乙肝5种治疗方案的临床疗效及成本效果分析. 魏振满等.中国医师杂志,第4卷第4期. 2002 |
慢性乙肝5种治疗方案的临床疗效及成本效果分析. 魏振满等.中国医师杂志,第4卷第4期. 2002 * |
胸腺五肽联合干扰素治疗慢性乙型肝炎临床分析. 苏华科等.实用医技杂志,第12卷第11期. 2005 |
胸腺五肽联合干扰素治疗慢性乙型肝炎临床分析. 苏华科等.实用医技杂志,第12卷第11期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1833721A (zh) | 2006-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11690909B2 (en) | Composition for treating and/or preventing Hepatitis B virus infection and the use thereof | |
CN1840177B (zh) | 胸腺肽α1注射液及其制备方法 | |
CN100435843C (zh) | 一种胸腺五肽与干扰素的组合物 | |
CN107213149A (zh) | 青蒿素类衍生物在制备治疗或辅助治疗自身免疫性甲状腺疾病药物中的用途 | |
CN101683519A (zh) | 一种胸腺肽α1与胸腺五肽的组合物及其制备方法 | |
CN1899279A (zh) | 绿原酸在制备具有保护肝脏功效药物的用途 | |
EP0294160A1 (en) | Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons | |
CN111437293A (zh) | 蟾酥提取物在制备治疗SARS-CoV-2病毒引起的感染性疾病的药物中的应用 | |
US20230181539A1 (en) | Methods for the treatment of coronavirus infections | |
CN104888196A (zh) | 一种稳定的干扰素α多剂量笔注射液 | |
CN100594930C (zh) | 以垂体前叶肾上腺皮质提取物为主要成份的组合药物及其制备方法和用途 | |
Yamamoto et al. | Further studies on the absorption of vitamin B12 following oral and parenteral administration | |
JPH06340549A (ja) | ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法 | |
KR100394382B1 (ko) | 천연사람α-인터페론으로구성된약학조성물 | |
CN1215996A (zh) | 减毒的非免疫原性痘病毒和副痘病毒衍生的多功能副痘病毒免疫诱导剂用作药物的新适应症 | |
CN106166295A (zh) | 一种治疗病毒性腹泻的干扰素口服制剂 | |
CN102380088A (zh) | 一种胸腺五肽注射液处方及制备方法 | |
CN1739794A (zh) | 一种胸腺素α1的水溶液制剂、其制备方法及应用 | |
CN1225249C (zh) | 一种提高免疫力的抗病毒药及制备方法 | |
US20100144855A1 (en) | APPLICATION OF SEDOISOPROSAN FOR PREPARATION OF MEDICINE FOR TREATMENT OF HUMAN HBeAg POSITIVE CHRONIC HEPATITIS B | |
CN102430112B (zh) | 干扰素α与硫酸沙丁胺醇的雾化吸入剂 | |
CN102416168B (zh) | 干扰素α与氨溴索的雾化吸入剂 | |
CN103054805A (zh) | 一种无针注射用注射剂的制备方法及应用 | |
CN102389565A (zh) | 一种治疗或预防动物疾病的药物 | |
Nash | Treatment with new synthetic analogue of vasopressin in diabetes insipidus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee after: Jilin Yixin pharmaceutical Limited by Share Ltd. Patentee after: Beijing Guodan Medicine Technology Development Co.,Ltd. Address before: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee before: Jilin A-Think Pharmaceutical Co.,Ltd. Patentee before: Beijing Guodan Medicine Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20090320 Address after: No. 1, one heart road, Shuangyang Economic Development Zone, Changchun: 130616 Patentee after: Jilin Yixin pharmaceutical Limited by Share Ltd. Address before: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee before: Jilin Yixin pharmaceutical Limited by Share Ltd. Patentee before: Beijing Guodan Medicine Technology Development Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JILIN YIXIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: BEIJING GUO DAN DRUG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20090320 |
|
C56 | Change in the name or address of the patentee |
Owner name: JILIN A-THINK PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: JILIN YIXIN PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 130616, No. 1, one heart road, Shuangyang Economic Development Zone, Changchun Patentee after: SINOPHARM A-THINK PHARMACEUTICAL Co.,Ltd. Address before: 130616, No. 1, one heart road, Shuangyang Economic Development Zone, Changchun Patentee before: Jilin Yixin pharmaceutical Limited by Share Ltd. |